Multipurpose prevention technologies (MPTs) are pharmaceutical products being developed for multiple indications, primarily prevention of HIV, pregnancy, and/or sexually transmitted infections. MPT products could be a combination of multiple drugs co-formulated for separate indications, or a single product with multiple indications.
This paper reviews MPT work published since 2013, including technical papers on aspects of product development, papers focused on issues that will be critical to future MPT clinical research and introduction, and selected papers concerning products for prevention of pregnancy or HIV/STIs. Collaborative efforts between researchers and funders aim to provide efficiencies in the product development process, building on experiences from both the contraceptive and vaginal microbicide fields.
Woodsong, C.; Holt, J.; Devlin, B.; Rosenberg, Z. Current Status of Multipurpose Prevention Technology (MPT) Development. Current Obstetrics and Gynecology Reports (2015) 4 (1) 43-52. [DOI: 10.1007/s13669-014-0107-6]
Current Status of Multipurpose Prevention Technology (MPT) Development